Literature DB >> 18000414

Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers.

Carine J Sakr1, Kim H Kreckmann, John W Green, Peter J Gillies, Julia L Reynolds, Robin C Leonard.   

Abstract

OBJECTIVE: To examine the relationship between serum perfluorooctanoate (PFOA), a biomarker of ammonium perfluorooctanoate (APFO) exposure, and lipids and liver enzymes in a cross-sectional study among workers with potential occupational exposure to APFO.
METHODS: We conducted a cross-sectional study of 1,025 active workers with potential exposure to APFO using linear regression to examine the relationship between PFOA and selected outcomes from a standard metabolic health screening survey, emphasizing lipids and liver enzymes.
RESULTS: Most outcome parameters were within normal limits. After adjusting for potential confounders, we observed a modest but statistically significant, positive relationship between serum PFOA and total cholesterol, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and gamma glutamyl aminotransferase (GGT). No associations were seen for high-density lipoprotein (HDL) or bilirubin; associations with AST (aspartate aminotransferase) and ALT (alanine transpeptidase) did not reach statistical significance.
CONCLUSIONS: Our findings indicate a modest positive association of PFOA on some lipid parameters and a need for follow-up studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18000414     DOI: 10.1097/JOM.0b013e318156eca3

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  50 in total

1.  Perfluoroalkyl acids, hyperuricemia and gout in adults: Analyses of NHANES 2009-2014.

Authors:  Franco Scinicariello; Melanie C Buser; Lina Balluz; Kimberly Gehle; H Edward Murray; Henry G Abadin; Roberta Attanasio
Journal:  Chemosphere       Date:  2020-06-20       Impact factor: 7.086

2.  Environmental and biological monitoring of persistent fluorinated compounds in Japan and their toxicities.

Authors:  Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2008-11-11       Impact factor: 3.674

3.  Concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) and their associations with human semen quality measurements.

Authors:  James H Raymer; Larry C Michael; William B Studabaker; Geary W Olsen; Carol S Sloan; Timothy Wilcosky; David K Walmer
Journal:  Reprod Toxicol       Date:  2011-06-29       Impact factor: 3.143

4.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

5.  Cord blood perfluoroalkyl substances in mothers exposed to the World Trade Center disaster during pregnancy.

Authors:  Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Morgan Robinson; Kurunthachalam Kannan; Leonardo Trasande; Julie Herbstman
Journal:  Environ Pollut       Date:  2018-12-11       Impact factor: 8.071

6.  Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women.

Authors:  Emily S Barrett; Chongshu Chen; Sally W Thurston; Line Småstuen Haug; Azemira Sabaredzovic; Frøydis Nyborg Fjeldheim; Hanne Frydenberg; Susan F Lipson; Peter T Ellison; Inger Thune
Journal:  Fertil Steril       Date:  2015-03-04       Impact factor: 7.329

7.  Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population.

Authors:  Jessica W Nelson; Elizabeth E Hatch; Thomas F Webster
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

8.  Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.

Authors:  Kyle Steenland; Sarah Tinker; Anoop Shankar; Alan Ducatman
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

Review 9.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

10.  Predictors of PFOA levels in a community surrounding a chemical plant.

Authors:  Kyle Steenland; Chuangfang Jin; Jessica MacNeil; Cathy Lally; Alan Ducatman; Veronica Vieira; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2009-03-23       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.